Sort
27,075 grants matching “cholesterol”
Molecular Mechanisms of TRIB1 Regulation of Hepatic Metabolism
$599,157Robert Clayton Bauer · Columbia University Health Sciences · R01 · FY2025 · DK
Nef
$599,090Thomas C Alber · University Of California, San Francisco · P50 · FY2011 · GM
Development Of New Chemotherapeutics For Tuberculosis
$599,050Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Therapeutic potential of CRISPR/Cas9 genome engineering in humanized mouse models
$599,025Karl-Dimiter Bissig · Baylor College Of Medicine · R01 · FY2018 · HL
Therapeutic potential of CRISPR/Cas9 genome engineering in humanized mouse models
$599,025Karl-Dimiter Bissig · Baylor College Of Medicine · R01 · FY2019 · HL
Therapeutic potential of CRISPR/Cas9 genome engineering in humanized mouse models
$599,025Karl-Dimiter Bissig · Baylor College Of Medicine · R01 · FY2017 · HL
Deciphering and disabling lysosome-dependent mechanisms of neurodegeneration
$598,950Roberto Zoncu · University Of California Berkeley · R01 · FY2024 · NS
Neighborhood Environments and Cardiometabolic Disorders in Hispanic/Latinos
$598,928Matthew A Allison · University Of California, San Diego · R01 · FY2017 · DK
Development, testing, and implementation of virtual statin associated muscle symptom (SAMS) management
$598,919Jordan Bradley King · University Of Utah · R01 · FY2023 · HL
New Media Obesity Treatment in Community Health Centers
$598,806Gary G Bennett · Duke University · R01 · FY2015 · DK
Phenotypic assay for drug discovery and personalized medicine based on real-time vibrational spectroscopy enhanced by plasmonic metasurfaces
$598,729Gennady Shvets · Cornell University · R21 · FY2020 · CA
Characterization of the nutrient assimilation pathways in M. tuberculosis
$598,288Brian C Vanderven · Cornell University · R01 · FY2024 · AI
Characterization of the nutrient assimilation pathways in M. tuberculosis
$598,288Brian C Vanderven · Cornell University · R01 · FY2023 · AI
Impact of sex differences on molecular determinants of AD risk and responsiveness to treatment
$598,003Bernard G. Schreurs · West Virginia University · R01 · FY2022 · AG
Impact of sex differences on molecular determinants of AD risk and responsiveness to treatment
$598,003Bernard G. Schreurs · West Virginia University · R01 · FY2024 · AG
Impact of sex differences on molecular determinants of AD risk and responsiveness to treatment
$598,003Bernard G. Schreurs · West Virginia University · R01 · FY2023 · AG
Modulation of Enothelial Vasomotor and Antithrombotic Functions by Antioxidants,
$597,999Donald D Heistad · University Of Iowa · P01 · FY2010 · HL
Epidemiology of Coronary Heart Disease of Men Aged 40+
$597,972University Of Pittsburgh At Pittsburgh · R01 · FY2003 · HL
A Targeted Self-Management Intervention for Reducing Stroke Risk Factors in High Risk Ugandans
$597,855Martha X Sajatovic · Case Western Reserve University · R01 · FY2023 · NS
Multifunctional Regulation of Prostate Cancer Metabolism by Sigma1 Modulators
$597,742Felix Jinhyun Kim · Thomas Jefferson University · R01 · FY2024 · CA
Molecular and Cellular Mechanisms of Calcific Aortic Stenosis
$597,611Bin Zhou · Albert Einstein College Of Medicine · R01 · FY2012 · HL
Multiplex Analysis of Inborn Errors of Metabolism
$597,597Michael H Gelb · University Of Washington · R01 · FY2016 · DK
Identifying genes underlying linkage peaks for clusters of CVD risk factors
$597,363Karen L Edwards · University Of California-Irvine · R01 · FY2014 · HL
HMG CoA Reductase: Molecular Mechanisms for Translational Control and Insig-media
$597,354Russell Alfred Debose-Boyd · Ut Southwestern Medical Center · P01 · FY2011 · HL
HDL Composition/Function and Coronary Plaque Formation
$597,309Bela F Asztalos · Tufts University Boston · R01 · FY2016 · HL